These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25585955)

  • 41. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres.
    Ibrahim MA; Ismail A; Fetouh MI; Göpferich A
    J Control Release; 2005 Sep; 106(3):241-52. PubMed ID: 15970349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lactic acid triggers, in vitro, thiomersal to degrade protein in the presence of PLGA microspheres.
    Namur JA; Takata CS; Moro AM; Politi MJ; De Araujo PS; Cuccovia IM; Da Costa MH
    Int J Pharm; 2004 Apr; 273(1-2):1-8. PubMed ID: 15010124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release.
    Park W; Na K
    Colloids Surf B Biointerfaces; 2009 Sep; 72(2):193-200. PubMed ID: 19414243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Crossley A; Czernuszka J
    J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acylation of peptides by lactic acid solutions.
    Lucke A; Göpferich A
    Eur J Pharm Biopharm; 2003 Jan; 55(1):27-33. PubMed ID: 12551701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
    Paillard-Giteau A; Tran VT; Thomas O; Garric X; Coudane J; Marchal S; Chourpa I; Benoît JP; Montero-Menei CN; Venier-Julienne MC
    Eur J Pharm Biopharm; 2010 Jun; 75(2):128-36. PubMed ID: 20226857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
    He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
    Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration.
    Nath SD; Son S; Sadiasa A; Min YK; Lee BT
    Int J Pharm; 2013 Feb; 443(1-2):87-94. PubMed ID: 23291448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC-MS/MS.
    Shirangi M; Hennink WE; Somsen GW; van Nostrum CF
    Pharm Res; 2015 Sep; 32(9):3044-54. PubMed ID: 25832500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z
    Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
    Li Z; Xiong F; He J; Dai X; Wang G
    Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A one-step modified method to reduce the burst initial release from PLGA microspheres.
    Zheng C; Liang W
    Drug Deliv; 2010 Feb; 17(2):77-82. PubMed ID: 20067365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Separation and identification of acylated leuprorelin inside PLGA microspheres.
    Guo N; Zhang Q; Sun Y; Yang H
    Int J Pharm; 2019 Apr; 560():273-281. PubMed ID: 30731258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation of High-Payload, Prolonged-Release Biodegradable Poly(lactic-co-glycolic acid)-Based Tacrolimus Microspheres Using the Single-Jet Electrospray Method.
    Pathak S; Gupta B; Poudel BK; Tran TH; Regmi S; Pham TT; Thapa RK; Kim MS; Yong CS; Kim JO; Jeong JH
    Chem Pharm Bull (Tokyo); 2016; 64(2):171-8. PubMed ID: 26833445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro evaluation of the effects of various additives and polymers on nerve growth factor microspheres.
    Sun H; Xu F; Guo D; Liu G
    Drug Dev Ind Pharm; 2014 Apr; 40(4):452-7. PubMed ID: 23565585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stabilization and immune response of HBsAg encapsulated within poly(lactic-co-glycolic acid) microspheres using HSA as a stabilizer.
    Xu W; He J; Wu G; Xiong F; Du H; Wang G
    Int J Pharm; 2015 Dec; 496(2):332-41. PubMed ID: 26453785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
    Xu W; Wei X; Wei K; Cao X; Zhong S
    Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of physical ageing on the performance of dexamethasone loaded PLGA microspheres.
    Rawat A; Burgess DJ
    Int J Pharm; 2011 Aug; 415(1-2):164-8. PubMed ID: 21664956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.